Company Profile

Gamma Medica Inc (AKA: Photon Imaging Inc~GM-I~Gamma Medica Inc~Gamma Medica - Ideas Inc)
Profile last edited on: 11/2/2020      CAGE: 1JST1      UEI: MPK3M8R122C4

Business Identifier: Digital gamma ray imaging system: now applied to detection of tumors in dense breast tissue.
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

12 Manor Parkway Unit 3
Salem, NH 03079
   (603) 952-4441
Location: Multiple
Congr. District: 02
County: Rockingham

Public Profile

Gamma Medica, Inc. is a women’s health company focused on overcoming the critical shortcomings of mammography and other screening modalities in the early detection of breast cancer. Part of the orginal firm founded in 1996, was involved in SBIR that year and very scative in the SBIR space. In 2011, the firm fell victim to tough times and in March 2013, the key technology and business focus of the firm was acquired through Chapter 11 sale and relocated to New Hampshire. The firm was able to raise $16M in new financing and retained some of former supporters The company’s LumaGEM® MBI system is a commercially available, FDA-cleared, fully solid-state digital imaging system utilizing dual-head Digital Direct Conversion Gamma Imaging™ (DDCGI™) technology for molecular breast imaging. With over 90 percent sensitivity and specificity, LumaGEM MBI has been shown to significantly improve cancer detection in women with dense breast tissue with fewer false positives relative to anatomical imaging technologies, such as MRI and whole breast ultrasound.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2011 2 NIH $3,000,000
Project Title: Molecular Breast Imaging To Guide Early-Stage Patient Care
2009 2 NIH $1,927,907
Project Title: Dual Headed CZT Breast Imager
2008 2 NIH $1,156,094
Project Title: Next generation micro CT
2008 2 NIH $800,935
Project Title: Dual Modality SPECT-MRI for In-Vivo Small Animal Imaging
2005 1 NIH $89,771
Project Title: Myocardial perfusion imaging & dedicated cardiac camera

Key People / Management

  Jim Calandra -- President and CEO

  Gina Caravaglia

  James Hugg -- Chief Technology Officer

  Thomas Langaard -- Executive Vice President and Chief Operating Officer

  Douglas J Wagenaar

  David Wilk -- Senior Vice President, Sales